Clinical trial · Observational
Quality of Life of Patients With Locally Advanced and Metastatic Prostate Cancer
Prospective Epidemiological Study to Determine the Variation in the Quality of Life of Patients With Locally Advanced and Metastatic Prostate Cancer (PROS-PROSQoLI Study)
NCT02853409CI-TRIAL-00036250PROS-PROSQoLIcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to evaluate possible changes in quality of life related to health (HRQL) in locally advanced and metastatic prostate cancer patients, after one year of follow-up.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Quality of life evolution, using the validated Prostate Cancer Specific Quality of Life Instrument (PROSQOLI)
- timeFrame
- 12 months
Secondary outcomes (9)
- measure
- Socio-demographic characteristics (percentage of patients (a) living married or living with a partner, (b) had completed primary studies, (c) retired or pensioners, (d) patients had a family history of PrCa)
- timeFrame
- 12 months
- measure
- Anthropometric Characteristics - Body Mass Index
- timeFrame
- Baseline
- measure
- Prostate-specific Antigen (PSA)
- timeFrame
- Baseline, 12 months
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Men ≥ 18 years old * Symptomatic prostate cancer patients who present symptoms due to prostate cancer disease * Capacity to comply with the protocol * Patient with an expected survival \> 12 months Exclusion Criteria: * Patients who are also participating in any other clinical study * Patient with other malignant diseases, apart from prostate cancer
References
Publications (0)
Data not yet available
No reference posted for this study.